The WACC of Ascelia Pharma AB (ACE.ST) is 5.9%.
| Range | Selected | |
| Cost of equity | 4.90% - 6.90% | 5.90% |
| Tax rate | 0.70% - 1.20% | 0.95% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.9% - 6.9% | 5.9% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.47 | 0.55 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 4.90% | 6.90% |
| Tax rate | 0.70% | 1.20% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.9% | 6.9% |
| Selected WACC | 5.9% | |